Blockbuster Neutralizing Antibody Treatment Already Approved For Use In Patients With Mild Illness...

F

Fred Bloggs

Guest
Coming out of virtual nowhere and exhibiting such unprecedented virus neutralizing performance in milli-scopic doses, this new n(eutralizing)AB treatment is already FDA approved for use in patients at same time as Phase 1 is beginning. This sounds kind of unheard of, but the huge number of cases rolling in makes for desperate measures.

https://www.biospace.com/article/releases/sorrento-receives-us-fda-clearance-to-proceed-with-phase-1-clinical-trials-for-sti-2020-covi-amg-in-healthy-volunteers-and-in-newly-diagnosed-covid-19-patients/
 

Welcome to EDABoard.com

Sponsor

Back
Top